NO20000694L - Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger - Google Patents

Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger

Info

Publication number
NO20000694L
NO20000694L NO20000694A NO20000694A NO20000694L NO 20000694 L NO20000694 L NO 20000694L NO 20000694 A NO20000694 A NO 20000694A NO 20000694 A NO20000694 A NO 20000694A NO 20000694 L NO20000694 L NO 20000694L
Authority
NO
Norway
Prior art keywords
side effects
contrast agents
preparation
largely free
contrast agent
Prior art date
Application number
NO20000694A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000694D0 (no
Inventor
Bernhard Sixt
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of NO20000694D0 publication Critical patent/NO20000694D0/no
Publication of NO20000694L publication Critical patent/NO20000694L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
NO20000694A 1997-08-21 2000-02-11 Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger NO20000694L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19736472A DE19736472C1 (de) 1997-08-21 1997-08-21 Verfahren zum Herstellen von weitgehend nebenwirkungsfreien Kontrastmitteln
PCT/EP1998/005305 WO1999010015A2 (fr) 1997-08-21 1998-08-20 Procede permettant de fabriquer des produits de contraste pratiquement depourvus d'effets secondaires

Publications (2)

Publication Number Publication Date
NO20000694D0 NO20000694D0 (no) 2000-02-11
NO20000694L true NO20000694L (no) 2000-02-29

Family

ID=7839778

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000694A NO20000694L (no) 1997-08-21 2000-02-11 Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger

Country Status (8)

Country Link
US (1) US6514480B1 (fr)
EP (1) EP1007105B1 (fr)
JP (1) JP2001513578A (fr)
AT (1) ATE235260T1 (fr)
AU (1) AU9264198A (fr)
DE (3) DE19736472C1 (fr)
NO (1) NO20000694L (fr)
WO (1) WO1999010015A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090030362A1 (en) * 2005-02-22 2009-01-29 Kaneka Corporation Contrast Agent-Removal System and Method of Activating the Contrast Agent-Removal System

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0829316B2 (ja) * 1987-10-16 1996-03-27 田辺製薬株式会社 パイロジェンの除去方法
US5204005A (en) * 1990-02-26 1993-04-20 Mallinckrodt, Inc. Reversed phase chromatographic process
IT1248741B (it) * 1991-02-26 1995-01-26 Bracco Spa Processo di concentrazione e di purificazione di composti organici
IT1256248B (it) * 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
IT1274027B (it) * 1994-03-03 1997-07-14 Zambon Spa Processo per la preparazione e purificazione di mezzi di contrasto iodurati
IT1282674B1 (it) * 1996-02-23 1998-03-31 Bracco Spa Processo per la purificazione di agenti contrastografici opacizzanti
IT1275427B (it) * 1995-05-16 1997-08-07 Bracco Spa Processo per la depirogenazione di soluzioni farmaceutiche iniettabili
IT1291623B1 (it) * 1997-04-18 1999-01-11 Bracco Spa Procedimento per la coniugazione di chelanti con molecole contenenti gruppi amminici

Also Published As

Publication number Publication date
WO1999010015A3 (fr) 1999-05-06
DE19736472C1 (de) 1999-04-22
WO1999010015A2 (fr) 1999-03-04
AU9264198A (en) 1999-03-16
NO20000694D0 (no) 2000-02-11
EP1007105B1 (fr) 2003-03-26
JP2001513578A (ja) 2001-09-04
ATE235260T1 (de) 2003-04-15
US6514480B1 (en) 2003-02-04
EP1007105A2 (fr) 2000-06-14
DE19881189D2 (de) 2001-01-04
DE59807666D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
ATE177421T1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
WO2003083485A3 (fr) Proteine destinee a etre utilisee dans des etats lies a une hypoxie
DK30391D0 (da) Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel
NO965621L (no) Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
HU214593B (hu) Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
WO1998039034A3 (fr) Utilisation de preparations contenant des anticorps anti-cd44 pour traiter certaines tumeurs et supprimer les reactions immunitaires
AU9363398A (en) Hepatitis c receptor protein cd81
NO20010940L (no) TAN-1057 derivater
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
NO20000694L (no) Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger
WO2001040465A3 (fr) Compositions et procedes de traitement de maladies d'ordre immunologique
SE9400524D0 (sv) Energipreparat
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
ATE317021T1 (de) Antisense modulierung von lfa-3
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
DE69323191D1 (de) Wasserlösliche retinoide
ATE184287T1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
ES2116574T3 (es) 4-guanidinobutiramida para mejorar la circulacion de la sangre.
EP1878795A3 (fr) Compositions et procédés pour le traitement de maladies liées au système immunitaire

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: TOVE AAS HELGE C/O GE HEALTHCARE, PATENTAVDELINGEN

FC2A Withdrawal, rejection or dismissal of laid open patent application